Algeria’s hospital funding crisis hits Covid-19 response

Algeria’s public hospitals were already under severe strain before Covid-19 struck. Years of underfunding had left facilities ill-equipped to handle routine demands, let alone a pandemic. The crisis exposed a system where financial constraints directly undermined healthcare delivery—and with it, the broader economy. Entrepreneurs, business founders, and the Algerian diaspora now face a critical question: how will these structural weaknesses reshape investment opportunities and policy shifts in the years ahead?

A funding gap that crippled response efforts

Private clinics, which account for 15% of Algeria’s hospital beds, attempted to fill some gaps. Yet regulatory restrictions on importing medical equipment limited their ability to scale up quickly. The government’s reliance on emergency imports—such as the 1,000 ventilators purchased from China in April 2020—highlighted Algeria’s dependence on foreign suppliers. Local manufacturers, including pharmaceutical firms like Saidal and Biopharm, saw a surge in demand for generic drugs and disinfectants, but raw material shortages hindered production.

Tax incentives stalled by bureaucracy

The Algerian diaspora played a role in bridging immediate gaps. Remittances to Algeria reached $1.8 billion in 2020, with some funds directed toward healthcare. Expatriates in France and Canada organized crowdfunding campaigns to purchase oxygen generators for hospitals in Tlemcen and Constantine. Others explored partnerships with local telemedicine startups, such as DZ Health, which saw a 300% user increase during the pandemic. Yet regulatory hurdles—including limits on foreign ownership in healthcare—deterred larger investments.

Social security strain and economic ripple effects

For businesses, the change translated to higher payroll costs, especially for small and medium-sized enterprises (SMEs) struggling with pandemic fallout. The move could further weaken consumer spending, already dented by unemployment and inflation. Entrepreneurs in retail and services must now factor in increased labor expenses while navigating uncertain demand.

Public-private partnerships and tech-driven solutions

Second, Algeria’s pharmaceutical sector may see consolidation. Larger players like Saidal could acquire smaller firms to achieve economies of scale in production. The Ministry of Health has also signaled plans to digitize hospital management systems, creating opportunities for tech startups specializing in health data analytics. Entrepreneurs with expertise in AI-driven diagnostics or electronic health records could position themselves to fill this gap.

Diaspora investments face regulatory uncertainty

Entrepreneurs and investors must monitor regulatory shifts closely. The healthcare sector’s fragmented supply chains and bureaucratic hurdles present both risks and opportunities. Those who can navigate licensing delays and policy changes may find openings in domestic manufacturing, telemedicine, and PPPs.

Key takeaway for entrepreneurs